Her answer: results vary from person to person and losing fat from one area isn't guaranteed, so treatment should fit individual needs.
Recap by typeshit. Post by @drsharwaridabhade on Instagram.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
She suggests following muscle mass, body fat and body water too, for a clearer view of how the body changes over time on treatment.
McGill researchers pooled data on 25,816 adults. Amycretin reached about 23.9% placebo-subtracted loss and retatrutide about 22.1%, though trials differed.
Loading…